Zdrowie i gospodarka · 17/10/2016

FDA Releases Guidance for Industry on Prior Approval Supplements Under Generic Drug User Fee Amendments

The FDA has announced the availability of a guidance document to help industry prepare for prior approval supplements and amendments to these supplements for abbreviated new drug applications, building on the Generic Drug User Fee Amendments of 2012.